Enzyme kinetics and interaction studies for human JNK1β1 and substrates Activating Transcription Factor 2 (ATF2) and c-Jun N-terminal kinase (c-Jun)

Journal of Biological Chemistry

Volumn 287, Issue 16, 2012, Pages 13291-13302

  Figuera Losada, Mariana ^a   LoGrasso, Philip V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; BIOCHEMICAL CHARACTERIZATION; C-JUN N-TERMINAL KINASE; ENZYMATIC ACTIVITIES; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; INTERACTION KINETICS; JNK-INTERACTING PROTEIN-1; KINETIC MECHANISM; REGULATORY PROTEIN; SEQUENTIAL MECHANISM; STRESS SIGNALS; TERNARY COMPLEX;

CELL DEATH; ENZYME ACTIVITY; ENZYME KINETICS; GLUCOSE; KINETICS; PHOSPHORYLATION; TRANSCRIPTION FACTORS;

SUBSTRATES;

ACTIVATING TRANSCRIPTION FACTOR 2; ADENOSINE TRIPHOSPHATE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; JIP1 PROTEIN; PEPTIDE DERIVATIVE; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE 1; STRESS ACTIVATED PROTEIN KINASE 1 BETA1; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; ENZYME KINETICS; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; HUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

ACTIVATING TRANSCRIPTION FACTOR 2; ALTERNATIVE SPLICING; CELL DEATH; ENZYME ACTIVATION; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KINETICS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 8; STRESS, PHYSIOLOGICAL; SUBSTRATE SPECIFICITY;

EID: 84859744067     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.323766     Document Type: Article

References (51)

1. Bender, K., Blattner, C., Knebel, A., Iordanov, M., Herrlich, P., and Rahmsdorf, H. J. (1997) UV-induced signal transduction. J. Photochem. Photobiol. B 37, 1-17
2. Dérijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. (1994) JNK1, a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037 (Pubitemid 24106383)
3. Hara, T., Namba, H., Yang, T. T., Nagayama, Y., Fukata, S., Kuma, K., Ishikawa, N., Ito, K., and Yamashita, S. (1998) Ionizing radiation activates c-Jun NH2-terminal kinase (JNK/SAPK) via a PKC-dependent pathway in human thyroid cells. Biochem. Biophys. Res. Commun. 244, 41-44 (Pubitemid 28419897)
4. Kyriakis, J. M., and Avruch, J. (1996) Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18, 567-577 (Pubitemid 26311096)
5. Westwick, J. K., Weitzel, C., Minden, A., Karin, M., and Brenner, D. A. (1994) Tumor necrosis factor α stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269, 26396-26401 (Pubitemid 24328461)
6. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252
7. Sluss, H. K., Barrett, T., Dérijard, B., and Davis, R. J. (1994) Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell Biol. 14, 8376-8384 (Pubitemid 24373586)
8. Kallunki, T., Su, B., Tsigelny, I., Sluss, H. K., Dérijard, B., Moore, G., Davis, R., and Karin, M. (1994) JNK2 contains a specificity- determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8, 2996-3007
9. Mohit, A. A., Martin, J. H., and Miller, C. A. (1995) p493F12 kinase. A novel MAP kinase expressed in a subset of neurons in the human nervous system. Neuron 14, 67-78
10. Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Dérijard, B., and Davis, R. J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760-2770 (Pubitemid 26176253)
11. Tuncman, G., Hirosumi, J., Solinas, G., Chang, L., Karin, M., and Hotamisligil, G. S. (2006) Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 103, 10741-10746 (Pubitemid 44078046)
12. Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., and Hotamisligil, G. S. (2002) A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (Pubitemid 35398190)
13. Kaneto, H., Nakatani, Y., Miyatsuka, T., Kawamori, D., Matsuoka, T. A., Matsuhisa, M., Kajimoto, Y., Ichijo, H., Yamasaki, Y., and Hori, M. (2004) Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat. Med. 10, 1128-1132 (Pubitemid 39424876)
14. Chang, L., Jones, Y., Ellisman, M. H., Goldstein, L. S., and Karin, M. (2003) JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev. Cell 4, 521-533 (Pubitemid 36437559)
15. Dong, C., Yang, D. D., Wysk, M., Whitmarsh, A. J., Davis, R. J., and Flavell, R. A. (1998) Defective T cell differentiation in the absence of Jnk1. Science 282, 2092-2095 (Pubitemid 29001267)
16. Liu, J., Minemoto, Y., and Lin, A. (2004) c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor α-induced c-Jun kinase activation and apoptosis. Mol. Cell. Biol. 24, 10844-10856 (Pubitemid 39603140)
17. Sabapathy, K., Hochedlinger, K., Nam, S. Y., Bauer, A., Karin, M., and Wagner, E. F. (2004) Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol. Cell 15, 713-725 (Pubitemid 39194902)
18. Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, E. C., Przedborski, S., Rakic, P., and Flavell, R. A. (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 101, 665-670 (Pubitemid 38084694)
19. Yang, D. D., Kuan, C. Y., Whitmarsh, A. J., Rincón, M., Zheng, T. S., Davis, R. J., Rakic, P., and Flavell, R. A. (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870 (Pubitemid 27462982)
20. Hayashi, T., Sakai, K., Sasaki, C., Zhang, W. R., Warita, H., and Abe, K. (2000) c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion. Neurosci. Lett. 284, 195-199 (Pubitemid 30204546)
21. Bruckner, S. R., Tammariello, S. P., Kuan, C. Y., Flavell, R. A., Rakic, P., and Estus, S. (2001) JNK3 contributes to c-Jun activation and apoptosis but not oxidative stress in nerve growth factor-deprived sympathetic neurons, J. Neurochem. 78, 298-303 (Pubitemid 32664411)
22. Klintworth, H., Newhouse, K., Li, T., Choi, W. S., Faigle, R., and Xia, Z. (2007) Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis. Toxicol. Sci. 97, 149-162 (Pubitemid 47072164)
23. Morishima, Y., Gotoh, Y., Zieg, J., Barrett, T., Takano, H., Flavell, R., Davis, R. J., Shirasaki, Y., and Greenberg, M. E. (2001) β-Amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J. Neurosci. 21, 7551-7560 (Pubitemid 32904954)
24. Dreskin, S. C., Thomas, G. W., Dale, S. N., and Heasley, L. E. (2001) Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells. J. Immunol. 166, 5646-5653 (Pubitemid 32374188)
25. Yang, J. Y., Moulin, N., van Bemmelen, M. X., Dubuis, G., Tawadros, T., Haefliger, J. A., Waeber, G., and Widmann, C. (2007) Splice variant-specific stabilization of JNKs by IB1/JIP1. Cell Signal. 19, 2201-2207 (Pubitemid 47353822)
26. Waeber, G., Delplanque, J., Bonny, C., Mooser, V., Steinmann, M., Widmann, C., Maillard, A., Miklossy, J., Dina, C., Hani, E. H., Vionnet, N., Nicod, P., Boutin, P., and Froguel, P. (2000) The gene MAPK8IP1, encoding islet brain-1, is a candidate for type 2 diabetes, Nat. Genet. 24, 291-295 (Pubitemid 30132201)
27. Ember, B., and LoGrasso, P. (2008) Mechanistic characterization for c-Jun N-terminal kinase 1α1. Arch. Biochem. Biophys. 477, 324-329
28. Ember, B., Kamenecka, T., and LoGrasso, P. (2008) Kinetic mechanism and inhibitor characterization for c-Jun N-terminal kinase 3α1. Biochemistry 47, 3076-3084 (Pubitemid 351364901)
29. Niu, L., Chang, K. C., Wilson, S., Tran, P., Zuo, F., and Swinney, D. C. (2007) Kinetic characterization of human JNK2α2 reaction mechanism using substrate competitive inhibitors. Biochemistry 46, 4775-4784 (Pubitemid 46651200)
30. Lisnock, J., Griffin, P., Calaycay, J., Frantz, B., Parsons, J., O'Keefe, S. J., and LoGrasso, P. (2000) Activation of JNK3α1 requires both MKK4 and MKK7. Kinetic characterization of in vitro phosphorylated JNK3α1. Biochemistry 39, 3141-3148
31. Leatherbarrow, R. J. (2001) GraFit, 5 Ed., Erithacus Software Limited, Surrey, United Kingdom
32. Barr, R. K., Kendrick, T. S., and Bogoyevitch, M. A. (2002) Identification of the critical features of a small peptide inhibitor of JNK activity. J. Biol. Chem. 277, 10987-10997 (Pubitemid 34952855)
33. Segel, I. H. (1975) Enzyme Kinetics, Wiley-Interscience, New York
34. Arthur, P. G., Matich, G. P., Pang, W. W., Yu, D. Y., and Bogoyevitch, M. A. (2007) Necrotic death of neurons following an excitotoxic insult is prevented by a peptide inhibitor of c-Jun N-terminal kinase. J. Neurochem. 102, 65-76 (Pubitemid 46906274)
35. Bowers, S., Truong, A. P., Neitz, R. J., Neitzel, M., Probst, G. D., Hom, R. K., Peterson, B., Galemmo, R. A., Jr., Konradi, A. W., Sham, H. L., Tóth, G., Pan, H., Yao, N., Artis, D. R., Brigham, E. F., Quinn, K. P., Sauer, J. M., Powell, K., Ruslim, L., Ren, Z., Bard, F., Yednock, T. A., and Griswold-Prenner, I. (2011) Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene-based JNK inhibitor. Bioorg. Med. Chem. Lett. 21, 1838-1843
36. Chamberlain, S. D., Redman, A. M., Wilson, J. W., Deanda, F., Shotwell, J. B., Gerding, R., Lei, H., Yang, B., Stevens, K. L., Hassell, A. M., Shewchuk, L. M., Leesnitzer, M. A., Smith, J. L., Sabbatini, P., Atkins, C., Groy, A., Rowand, J. L., Kumar, R., Mook, R. A., Jr., Moorthy, G., and Patnaik, S. (2009) Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity. Bioorg. Med. Chem. Lett. 19, 360-364
37. Heo, Y. S., Kim, S. K., Seo, C. I., Kim, Y. K., Sung, B. J., Lee, H. S., Lee, J. I., Park, S. Y., Kim, J. H., Hwang, K. Y., Hyun, Y. L., Jeon, Y. H., Ro, S., Cho, J. M., Lee, T. G., and Yang, C. H. (2004) Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J. 23, 2185-2195 (Pubitemid 38833228)
38. Hom, R. K., Bowers, S., Sealy, J. M., Truong, A. P., Probst, G. D., Neitzel, M. L., Neitz, R. J., Fang, L., Brogley, L., Wu, J., Konradi, A. W., Sham, H. L., Tóth, G., Pan, H., Yao, N., Artis, D. R., Quinn, K., Sauer, J. M., Powell, K., Ren, Z., Bard, F., Yednock, T. A., and Griswold-Prenner, I. (2010) Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK. Bioorg. Med. Chem. Lett. 20, 7303-7307
39. Kamenecka, T., Jiang, R., Song, X., Duckett, D., Chen, W., Ling, Y. Y., Habel, J., Laughlin, J. D., Chambers, J., Figuera-Losada, M., Cameron, M. D., Lin, L., Ruiz, C. H., and LoGrasso, P. V. (2010) Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-Jun N-terminal kinase (JNK) inhibitors. J. Med. Chem. 53, 419-431
40. Probst, G. D., Bowers, S., Sealy, J. M., Truong, A. P., Hom, R. K., Galemmo, R. A., Jr., Konradi, A. W., Sham, H. L., Quincy, D. A., Pan, H., Yao, N., Lin, M., Tóth, G., Artis, D. R., Zmolek, W., Wong, K., Qin, A., Lorentzen, C., Nakamura, D. F., Quinn, K. P., Sauer, J. M., Powell, K., Ruslim, L., Wright, S., Chereau, D., Ren, Z., Anderson, J. P., Bard, F., Yednock, T. A., and Griswold-Prenner, I. (2011) Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration. Bioorg. Med. Chem. Lett. 21, 315-319
41. Scapin, G., Patel, S. B., Lisnock, J., Becker, J. W., and LoGrasso, P. V. (2003) The structure of JNK3 in complex with small molecule inhibitors. Structural basis for potency and selectivity. Chem. Biol. 10, 705-712 (Pubitemid 37089845)
42. Stebbins, J. L., De, S. K., Machleidt, T., Becattini, B., Vazquez, J., Kuntzen, C., Chen, L. H., Cellitti, J. F., Riel-Mehan, M., Emdadi, A., Solinas, G., Karin, M., and Pellecchia, M. (2008) Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc. Natl. Acad. Sci. U.S.A. 105, 16809-16813
43. O'Shannessy, D. J., and Winzor, D. J. (1996) Interpretation of deviations from pseudo-first order kinetic behavior in the characterization of ligand binding by biosensor technology. Anal. Biochem. 236, 275-283 (Pubitemid 26136106)
44. Abdiche, Y., Malashock, D., Pinkerton, A., and Pons, J. (2008) Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet. Anal. Biochem. 377, 209-217
45. Bayer, E. A., and Wilchek, M. (1980) The use of the avidin-biotin complex as a tool in molecular biology. Methods Biochem. Anal. 26, 1-45
46. Green, N. M. (1975) Avidin. Adv. Protein Chem. 29, 85-133
47. Edwards, P. R., Gill, A., Pollard-Knight, D. V., Hoare, M., Buckle, P. E., Lowe, P. A., and Leatherbarrow, R. J. (1995) Kinetics of protein-protein interactions at the surface of an optical biosensor. Anal. Biochem. 231, 210-217
48. Gilbert, H. F. (2000) Basic Concepts in Biochemistry: A Students Survival Guide, 2nd Ed., McGraw-Hill, Health Professions Division, New York
49. Ngoei, K. R., Catimel, B., Church, N., Lio, D. S., Dogovski, C., Perugini, M. A., Watt, P. M., Cheng, H. C., Ng, D. C., and Bogoyevitch, M. A. (2011) Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide. Biochem. J. 434, 399-413
50. Rubinfeld, H., and Seger, R. (2005) The ERK cascade. A prototype of MAPK signaling. Mol. Biotechnol. 31, 151-174 (Pubitemid 41306584)
51. Burkhard, K. A., Chen, F., and Shapiro, P. (2011) Quantitative analysis of ERK2 interactions with substrate proteins. Roles for kinase docking domains and activity in determining binding affinity. J. Biol. Chem. 286, 2477-2485